cyclosporine has been researched along with Leukemia, Myeloid, Acute in 143 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 56 (39.16) | 18.2507 |
| 2000's | 45 (31.47) | 29.6817 |
| 2010's | 33 (23.08) | 24.3611 |
| 2020's | 9 (6.29) | 2.80 |
| Authors | Studies |
|---|---|
| Aljurf, M; Bazarbachi, A; Bondarenko, S; Bourhis, JH; Brissot, E; Bug, G; Canaani, J; Choi, G; Ciceri, F; Cornelissen, JJ; Dholaria, B; Esteve, J; Gedde-Dahl, T; Giebel, S; Koc, Y; Labopin, M; Meijer, E; Mohty, M; Nagler, A; Niittyvuopio, R; Savani, B; Socié, G; Spyridonidis, A; Wu, D | 1 |
| Battipaglia, G; Bazarbachi, A; Blaise, D; Castagna, L; Chevallier, P; Daguindau, E; Diez-Martin, JL; Grillo, G; Koc, Y; Labopin, M; López-Jiménez, J; Mohty, M; Nagler, A; Ruggeri, A; Vitek, A | 1 |
| Abermil, N; Bilhou-Nabera, C; Chaquin, M; Delhommeau, F; Favale, F; Feger, F; Genthon, A; Guermouche, H; Heuberger, L; Hirsch, P; Hirschauer, C; Lapusan, S; Legrand, O; Memoli, M; Mohty, M; Soret, L; Sourdeau, E; Suner, L | 1 |
| Al-Azab, G; Samra, M; Shams, MEE; Sharaf El-Deen, MO; Soliman, MM | 1 |
| Bertrand, Y; Bordigoni, P; Bruno, B; Cousin, E; Dalle, JH; de La Tour, RP; Drunat, S; Eliaou, JF; Freycon, C; Galambrun, C; Gandemer, V; Jonveaux, P; Oger, E; Paillard, C; Pertuisel, S; Pochon, C; Rohrlich, P; Schneider, P; Semana, G; Simon, P | 1 |
| Dou, A; Fang, J; Feng, S; Halene, S; Hawkins, C; He, X; Lawley, L; Mizukawa, B; Patel, A; Roman-Rivera, A; Wunderlich, M; Zhang, J | 1 |
| Haghighat, S; Haghighinejad, H; Namdari, N; Ramzi, M | 1 |
| Chatterjee, G; Kapoor, R; Nivargi, S; Rastogi, N; Sharma, A; Yadav, SP | 1 |
| Al-Shaibani, Z; Chen, C; Kim, DDH; Kumar, R; Lam, W; Law, AD; Lipton, JH; Loach, D; Mattsson, J; Michelis, FV; Nampoothiri, RV; Viswabandya, A | 1 |
| Balleari, E; Bernal, T; Beyne-Rauzy, O; Bordessoule, D; Calabuig, M; Cametti, G; Campelo, MD; Cheze, S; Cony-Makhoul, P; Dreyfus, F; Fenaux, P; Fensterl, J; Ferrero, D; Gaidano, G; Germing, U; Gioia, D; Götze, K; Guerci-Bresler, A; Hamel, JF; Kaivers, J; Kelaidi, C; Komrokji, R; Kotsianidis, I; Müller-Thomas, C; Pane, F; Park, S; Ramos, F; Roboz, GJ; Rose, C; Sanna, A; Santini, V; Sanz, GF; Sapena, R; Sekeres, MA; Stamatoullas, A; Steensma, DP; Thépot, S; Toma, A; Vey, N; Wattel, E | 1 |
| Alyea, EP; Bashey, A; Deeg, HJ; Devine, SM; Fernandez, HF; Geller, NL; Giralt, S; Hamadani, M; Horowitz, MM; Horwitz, ME; Le-Rademacher, J; Leifer, E; Logan, BR; Maziarz, RT; Mendizabal, AM; Pasquini, MC; Porter, DL; Scott, BL; Warlick, ED; Wu, J | 1 |
| Baaj, ME; Doghmi, K; Eddou, H; Khalloufi, A; Mahtat, M; Mikdame, M; Moudden, MK; Sina, M; Zinebi, A | 1 |
| Alessandrino, PE; Angelucci, E; Bacigalupo, A; Brune, M; Bug, G; Chiusolo, P; Di Grazia, C; Dominietto, A; Ferrara, F; Finizio, O; Gualandi, F; Mordini, N; Olivieri, A; Raiola, AM; Van Lint, MT | 1 |
| Alimoghaddam, K; Khodabakhsh, A; Nafissi, S; Sinaei, F | 1 |
| Khamenehfar, A; Li, PCH; Sharifi Noghabi, H; Soo, M | 1 |
| Fang, BJ; Fu, YW; Gui, RR; Li, YF; Li, Z; Lyu, TX; Song, YP; Wang, J; Wei, XD; Yu, FK; Zhang, BL; Zhang, WL; Zhang, YL; Zhao, HF; Zhou, J; Zhou, KS; Zu, YL | 1 |
| Chen, TL; Estey, EH; Gardner, KM; Markle, LJ; Othus, M; Walter, RB | 1 |
| Tohyama, K | 1 |
| Bao, JA; Ding, XL; Miao, LY; Xue, L; Zhang, JJ; Zhang, WW | 1 |
| Beck, J; Gruhn, B; Steinbach, D; Weiss, M; Zintl, F | 1 |
| Gupta, V; Hamad, N; Kim, DD; Kuruvilla, J; Lipton, JH; Messner, HA; Michelis, FV; Seftel, M; Shanavas, M; Uhm, J | 1 |
| Bornhäuser, M; Brendel, C; Burchert, A; Charles, J; Ellenrieder, V; Gattenlöhner, S; Hessmann, E; Inselmann, S; Metzelder, SK; Michel, C; Neubauer, A; Rehberger, M; Sohlbach, K; Solovey, M; Stiewe, T; Ten Haaf, A; von Bonin, M; Wang, Y | 1 |
| Hama, A; Ito, E; Ito, M; Kobayashi, R; Kojima, S; Kosaka, Y; Muramatsu, H; Narita, A; Ohara, A; Ohga, S; Takahashi, Y; Tsuchida, M; Yabe, H | 1 |
| Ding, K; Geng, L; Liu, H; Sun, G; Sun, Z; Tang, B; Wang, L; Wang, X; Zheng, C | 1 |
| Boğa, C; Gereklioğlu, Ç; Gökgöz, Z; Özdoğu, H; Solmaz, S; Yeral, M | 1 |
| Bertrand, Y; Bleyzac, N; Cuzzubbo, D; Domenech, C; Dubois, V; Garnier, N; Goutagny, MP; Goutelle, S; Grardel, N; Janoly-Duménil, A; Plesa, A; Rénard, C | 1 |
| Colpak, AI; Gocmen, R; Goker, H; Kaya, AA; Onder, H | 1 |
| Atsuta, Y; Fukuda, T; Ichinohe, T; Inamoto, Y; Kanamori, H; Murata, M; Ohashi, K; Onishi, Y; Ozawa, Y; Sakai, R; Takahashi, S; Takanashi, M; Terakura, S; Teshima, T; Uchida, N; Wake, A; Yamaguchi, H; Yamaguchi, T | 1 |
| Andreoli, A; Boissel, N; de Latour, RP; Dhédin, N; Granier, C; Larghero, J; Lengliné, E; Masson, E; Robin, M; Schlageter, MH; Socié, G; Vignon, M | 1 |
| Amrolia, P; Ancliff, P; Bonanomi, S; Bonnanomi, S; Connor, P; Goulden, N; Hemmatpour, S; McCloskey, D; Rao, K; Veys, P; Webb, D | 1 |
| Appelbaum, FR; Coombs, RW; Corey, L; Harrington, RD; Malhotra, U; Manley, TJ; McNevin, J; Riddell, SR; Storb, R; Woolfrey, AE | 1 |
| Batlle, M; Montané, E; Ribera, JM; Vives, S | 1 |
| Chen, SG; Li, GY; Liu, JZ; Wang, CB; Wang, LX; Zhang, B | 1 |
| Bramsiepe, I; Danz, B; Eismann, R; Fiedler, E; Marsch, WC; Neid, T; Wohlrab, J | 1 |
| Cho, GJ; Choi, YJ; Chung, JS; Kwon, BR; Seol, YM; Shin, HJ; Song, MK | 1 |
| Appelbaum, FR; Chauncey, TR; Chen, IM; Dakhil, SR; Erba, HP; Gundacker, H; Kopecky, KJ; List, AF; Shadman, M; Slovak, ML; Willman, CL | 1 |
| Arnold, R; Dörken, B; Hemmati, PG; le Coutre, P; Massenkeil, G; Neuburger, S; Terwey, TH; Vuong, LG | 1 |
| Elad, S; Gesundheit, B; Levovic, A; Miron, S; Or, R; Resnick, IB; Shapira, MY; Slavin, S; Tsirigotis, PD; Yoffe, L; Zilberman, I | 1 |
| du Toit, C; McDonald, A; Novitzky, N; Thomas, V | 1 |
| Goto, M; Kakihana, Y; Kawano, Y; Kodama, Y; Nishikawa, T; Okamoto, Y; Shinkoda, Y; Tanabe, T | 1 |
| Brunstein, CG; DeFor, TE; Oran, B; Wagner, JE; Weisdorf, DJ | 1 |
| Beutel, G; Buchholz, S; Dammann, E; Eder, M; Ganser, A; Krauter, J; Stadler, M; Trummer, A | 1 |
| Li, X; Lingyun, W; Luxi, S; Qi, Z; Qiusheng, C; Xiao, L | 1 |
| Bertz, H; Engelhardt, M; Finke, J; Grüllich, C; Ihorst, G; Marks, R; Spyridonidis, A; Wäsch, R | 1 |
| Abbas, AA; Jastaniah, WA | 1 |
| Campbell, LJ; Cheah, CY; Chin, LK; MacKinnon, RN; Michael, PM | 1 |
| Bertz, H; Christopoulos, P; Finke, J; Ihorst, G; Marks, R; Wäsch, R | 1 |
| Berkowitz, J; Bernard, L; Hogge, DE; Kim, HP; Nitta, J | 1 |
| Blaise, D; Siddiqi, T | 1 |
| Hamano, Y; Ikeda, Y; Ishihara, D; Kawamura, J; Mori, T; Okamoto, S; Sato, N; Watanabe, R | 1 |
| Ikeda, Y; Matsuzaki, M; Sakemi, T; Sano, M | 1 |
| Albitar, M; Cortes, J; Estey, E; Faderl, S; Garcia-Manero, G; Giles, F; Kantarjian, H; Keating, M; O'Brien, S; Thomas, D; Tsimberidou, A; Verstovsek, S | 1 |
| Fujimori, Y; Hara, H; Kakishita, E; Mori, A; Okada, M; Okamoto, T; Takatsuka, H; Wakae, T | 1 |
| Apostolidou, E; Cortes, J; Estey, E; Giles, FJ; Kantarjian, H; Tsimberidou, A | 1 |
| Fujisawa, Y; Hamaki, T; Heike, Y; Hori, A; Imataki, O; Kami, M; Kim, SW; Kishi, Y; Kojima, R; Makimoto, A; Masuo, S; Murashige, N; Sakiyama, M; Takaue, Y; Tanosaki, R | 1 |
| Chen, Y; Han, W; Hong, H; Huang, X; Lu, D | 1 |
| Ehlert, K; Groll, AH; Kolve, H; Paulussen, M; Vormoor, J | 1 |
| Cortes, J; Giles, F; Kantarjian, H; Ravandi, F | 1 |
| Takeshita, A | 1 |
| Koyama, M; Kunisaki, Y; Matsue, K; Matsuoka, K; Takeuchi, M | 1 |
| Chen, H; Chen, YH; Dong, LJ; Han, W; Huang, XJ; Jiang, Q; Liu, DH; Liu, KY; Lu, DP; Lu, J; Ren, HY; Wang, JB; Wu, T; Xu, LP | 1 |
| Homma, CI; Hori, A; Kami, M; Katori, H; Kim, SW; Kishi, Y; Kojima, R; Kusumi, E; Masuo, S; Mitamura, T; Murashige, N; Sakiyama, M; Takaue, Y; Takeuchi, K | 1 |
| Appelbaum, FR; Banker, DE; Cronk, MR; Mayer, S; Pirga, JL; Walter, RB | 1 |
| Chandra, J; Naithani, R; Sharma, S | 1 |
| Arceci, RJ; Becton, D; Behm, FG; Chang, MN; Dahl, GV; Head, DR; Lacayo, NJ; Raimondi, SC; Ravindranath, Y; Sikic, BI; Stine, KC; Weinstein, H | 1 |
| Agura, E; Al-Ali, H; Bruno, B; Chauncey, T; Cordonnier, C; Gratwohl, A; Greinix, H; Hegenbart, U; Lange, T; Maloney, D; Maris, MB; Maziarz, RT; McSweeney, P; Niederwieser, D; Petersen, F; Rio, B; Sandmaier, BM; Shizuru, JA; Storb, R; Storer, B | 1 |
| Fang, J; Guo, T; Jiang, H; Liu, F; Xia, L; You, Y; Zhang, C; Zou, P | 1 |
| Creutzig, U; den Boer, ML; Hählen, K; Kaspers, GJ; Kazemier, KM; Loonen, AH; Pieters, R; Reinhardt, D; Zwaan, CM | 1 |
| Chen, SN; Fu, ZZ; Han, Y; He, GS; Jin, ZM; Ma, X; Miao, M; Qiu, HY; Sun, AN; Tang, XW; Wang, Y; Wu, DP; Xue, SL; Zhao, Y | 1 |
| Jiang, ZX; Liu, LX; Sun, H; Sun, L; Wan, DM; Xie, XS | 1 |
| Cantú-Rodríguez, OG; Gómez-Almaguer, D; Gonzalez-Llano, O; Gutierrez-Aguirre, CH; Jaime-Pérez, JC; Martinez-González, O; Morales-Toquero, A; Ruiz-Argüelles, GJ; Salazar-Riojas, R; Tarín-Arzaga, LC | 1 |
| Bahlis, NJ; Balogh, A; Brown, CB; Chaudhry, MA; Geddes, M; Larratt, L; Quinlan, D; Russell, JA; Savoie, ML; Stewart, DA; Storek, J; Turner, AR | 1 |
| Usui, N | 1 |
| Avcu, F; Baran, Y; Gündüz, U; Gür, B; Kaya, P; Ural, AU | 1 |
| Bertz, H; Finke, J; Grüllich, C; Müller, CI; Spyridonidis, A | 1 |
| Cho, KH; Choi, SM; Kim, BC; Kim, MK; Lee, SH; Park, MS; Yang, DH | 1 |
| Arseniev, L; Bähre, O; Battmer, K; Berenson, RJ; Casper, J; Diedrich, H; Jacobs, R; Kadar, JG; Kühl, J; Link, H; Poliwoda, H; Schubert, J | 1 |
| Diem, E; Gotschim, A; Maier, H; Ortel, B | 1 |
| De Witte, T; Dompeling, EC; Schattenberg, A; Swaak, AJ; Vreugdenhil, G | 1 |
| Casoli, P; Tumiati, B | 1 |
| Delmer, A; Marie, JP; Zhou, D; Zittoun, R | 1 |
| Kimball, J; Rosenfeld, SJ; Vining, D; Young, NS | 1 |
| Lee, L; Maxymiw, WG; Messner, HA; Miller, PA; Rotstein, LE | 1 |
| Bright, E; Fischer, A; Hess, A; Jones, R; Kennedy, MJ; Morris, L; Ruvolo, P; Vogelsang, G | 1 |
| Abla, O; Arcese, W; Boni, L; Di Bartolomeo, P; Dini, G; Iori, AP; Locatelli, F; Polchi, P; Rossetti, F; Uderzo, C | 1 |
| Abella, E; de Planque, MM; Eisenbrey, AB; Karanes, C; Lum, LG; Ratanatharathorn, V; Ravindranath, Y; Schultz, KR; Sensenbrenner, LL; Uberti, JP | 1 |
| Catovsky, D; Horton, C; Mehta, J; Milan, S; Powles, R; Tait, D; Treleaven, J | 1 |
| Kushibiki, Y; Omata, F; Takahashi, H; Ueno, F | 1 |
| Aschan, J; Ringdén, O | 1 |
| Lee, EJ; Ordóñez, JV; Ross, DD; Schiffer, CA; Sridhara, R; Wooten, PJ | 1 |
| Cornblatt, B; Lee, EJ; Levy, C; Ross, DD; Schiffer, CA; Sridhara, R; Tong, Y; Wooten, PJ | 1 |
| Farmer, ER; Hess, AD; Jones, RJ; Santos, GW; Vogelsang, GB; Yeager, AM | 1 |
| Bafundi, P; Chan, CK; Fyles, G; Hyland, RH; Messner, H; Payne, L; Yeung, M | 1 |
| Buckley, JD; Feig, SA; Hammond, GD; Kim, T; Lampkin, B; Nesbit, ME; Versteeg, CM; Woods, WG | 1 |
| Dörries, K; Schneider, EM | 1 |
| Belanger, R; Boileau, J; Bonny, Y; Kassis, J; Lacombe, M; Lalonde, Y; Lavallee, R; Perreault, C; Roy, DC; von Bueltzingsloewen, A | 1 |
| Biggs, JC; Champlin, RE; Deeg, HJ; Dicke, K; Gale, RP; Horowitz, MM; Masaoka, T; Powles, RL; Ringdén, O; Sondel, P | 1 |
| Estey, EH; Simon, RM; Thall, PF | 1 |
| Asaka, M; Hashino, S; Imamura, M; Kasai, M; Kobayashi, S; Musashi, M; Tanaka, J | 1 |
| List, AF | 1 |
| Baraldo, M; Cossettini, P; Furlanut, M; Pea, F; Wu, G | 1 |
| Hamai, K; Imai, H; Komatsuda, A; Miura, AB; Nakamoto, Y; Ohtani, H; Oyama, Y; Wakui, H | 1 |
| Eisen, T; Horton, C; Mehta, J; Meller, S; Middleton, G; Pinkerton, CR; Powles, R; Singhal, S; Tait, D; Treleaven, J | 1 |
| Choi, CH; Ling, V | 1 |
| Novik, Y; Oleksowicz, L; Wiernik, PH | 1 |
| Carriço, MK; Coelho, AM; Klumb, CE; Maia, RC; Noronha, H; Ruimanek, VM; Vasconcelos, FC | 1 |
| Li, S; Wang, C; Yao, C | 1 |
| Deguchi, S; Kikuchi, T; Miyata, A; Osada, T; Sanada, H | 1 |
| Baccarani, M; Baraldo, M; Damiani, D; Ermacora, A; Fanin, R; Furlanut, M; Michieli, M; Pea, F; Russo, D; Zaja, F | 1 |
| Barrett, AJ; Bunjes, D; Hale, G; Horowitz, MM; Prentice, HG; Spence, D; Waldmann, H; Zhang, MJ | 1 |
| Hołowiecki, J; Kopera, M; Krawczyk-Kuliś, M; Kruzel, T; Markiewicz, M; Wojciechowska, M; Wojnar, J | 1 |
| Jabłoński, M; Machaczka, M; Rucińska, M; Skotnicki, AB | 1 |
| Balguerie, X; Boullie, MC; Joly, P; Lauret, P; Tanasescu, S; Thomine, E; Tron, P; Vannier, JP | 1 |
| Antunes, NL; Boulad, F; George, D; Lis, E; Small, TN | 1 |
| Afify, Z; Shaw, PJ | 1 |
| Hamaguchi, M; Haneda, M; Iida, H; Kanie, T; Kodera, Y; Minami, S; Murata, M; Nishida, T; Suzuki, R; Taji, H | 1 |
| Choi, CH; Jeong, JH; Kee, KH; Kim, HS; Lim, DY; Min, YD; Park, YH; Rha, HS | 1 |
| Baccarani, M; Baraldo, M; Damiani, D; Ermacora, A; Fanin, R; Furlanut, M; Michieli, M; Pea, F; Russo, D | 1 |
| Elgie, AW; Lewandowicz, GM; Sargent, JM; Taylor, CG; Williamson, CJ | 1 |
| Langabeer, S; Pallis, M; Russell, NH; Turzanski, J | 1 |
| Legrand, O; Marie, JP; Perrot, JY; Simonin, G; Zittoun, R | 1 |
| Ağaoğlu, L; Anak, S; Erdem, S; Gedikoğlu, G; Hacibektaşoğlu, A; Karakaş, Z | 1 |
| Ahmed, T; Baskind, P; Beer, M; Chiao, JW; Feldman, E; Goff, H; Seiter, K; Stein, M | 1 |
| Goh, YT; How, GF; Hwang, WY; Tan, CH; Tan, HC | 1 |
| Arceci, RJ; Brophy, N; Chang, M; Dahl, GV; Dunussi-Joannopoulos, K; Lacayo, NJ; Sikic, BI; Weinstein, HJ | 1 |
| Chao, TY; Chen, CY; Chen, YC; Ho, CL | 1 |
| Appelbaum, FR; Bensinger, WI; Blume, KG; Bryant, E; Chauncey, TR; Flowers, ME; Georges, GE; Gooley, TA; Grumet, FC; Hegenbart, U; Kiem, HP; Maloney, DG; McSweeney, PA; Minor, S; Molina, AJ; Nash, RA; Niederwieser, D; Radich, J; Sandmaier, BM; Shizuru, JA; Storb, RF; Torok-Storb, B; Wagner, JL; Yu, C | 1 |
| Arai, K; Fukayama, M; Imashuku, S; Ito, E; Kitazawa, J; Yokoyama, M | 1 |
| Battmer, K; Dammann, E; Eder, M; Ganser, A; Hambach, L; Heil, G; Hertenstein, B; Stucki, A | 1 |
| Appelbaum, FR; Doroshow, JH; Dorr, R; Head, DR; Hynes, HE; Karanes, C; Kopecky, KJ; List, AF; Persons, DL; Shurafa, M; Slovak, ML; Willman, CL | 1 |
| Antinori, A; Chiusolo, P; Cingolani, A; De Luca, A; Laurenti, L; Leone, G; Ortona, L; Piccirillo, N; Rutella, S; Sica, S; Sorà, F | 1 |
| Corey, L; Geisler, WM | 1 |
| Eibl, M; Greinix, HT; Gritsch, B; Hinterberger, W; Kalhs, P; Knöbl, P; Krieger, O; Lechner, K; Linkesch, W; Lutz, D; Nachbaur, D; Niederwieser, D; Rosenmayr, A | 1 |
| Imamura, S; Kuwata, A; Shirasaki, H; Tsutani, H; Ueda, T; Yamashita, T; Yamauchi, T | 1 |
| Delmer, A; Helou, C; Marie, JP; Thevenin, D; Zittoun, R | 1 |
| Akan, H; Beksaç, M; Ertürk, S; Güneyli, A; Ikizünal, Y; Ilhan, O; Koç, H; Sardaş, OS | 1 |
| Brown, R; Stevens, M; Tiedemann, K; Vowels, M | 1 |
| Fukawa, H; Harano, H; Kanamori, H; Kodama, F; Maruta, A; Matsuzaki, M; Miyashita, H; Motomura, S; Okubo, T; Yoshiba, M | 1 |
| Bruckner-Tuderman, L; Burger, J; Gmür, J | 1 |
| Altomonte, V; Farmer, ER; Hess, AD; Jones, RJ; Santos, GW; Vogelsang, GB; Yeager, AM | 1 |
| Anasetti, C; Appelbaum, FR; Bensinger, W; Buckner, CD; Cliff, RA; Deeg, HJ; Doney, K; Hansen, J; Pepe, M; Storb, R | 1 |
| Chen, PM; Fan, FS; Hsiao, KI; Hu, ST; Liu, WT; Tzeng, CH | 1 |
| Hidaka, S; Hiraoka, A; Kobayashi, M; Matsunashi, T; Nakamura, H; Tejima, H; Tominaga, N; Yoshida, H; Yoshida, S; Yoshimura, M | 1 |
10 review(s) available for cyclosporine and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
[Myelodysplastic syndromes: treatment strategy up-to-date].
Topics: Antilymphocyte Serum; Azacitidine; Benzoates; Cyclosporine; Cytarabine; Deferasirox; Disease Progression; Drug Discovery; Drug Therapy, Combination; Erythropoietin; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Iron Chelating Agents; Lenalidomide; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Quality of Life; Risk Assessment; Thalidomide; Triazoles | 2014 |
Does antithymocyte globulin have a place in reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation?
Topics: Adult; Antilymphocyte Serum; Child; Comorbidity; Cyclophosphamide; Cyclosporine; Graft vs Leukemia Effect; Hematology; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2012 |
New agents in acute myeloid leukemia and other myeloid disorders.
Topics: Antineoplastic Agents; Cyclosporine; Cytosine; Deoxycytidine; Dioxolanes; Female; Gemcitabine; Humans; Immunosuppressive Agents; Immunotherapy; Leukemia, Myeloid, Acute; Male; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Survival Analysis; Treatment Outcome | 2004 |
[Recent advances in the treatment of acute myelogenous leukemia: a view of the new agents].
Topics: Alkyl and Aryl Transferases; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Benzoates; Cyclosporine; Cytarabine; Daunorubicin; Drug Design; Farnesyltranstransferase; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Nucleosides; Oxides; Prognosis; Radioisotopes; Remission Induction; Tetrahydronaphthalenes; Topoisomerase Inhibitors; Tretinoin; Verapamil | 2003 |
[Gemtuzumab ozogamicin as monotherapy and combination therapy for acute myelogenous leukemia].
Topics: Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclosporine; Drug Administration Schedule; Gemtuzumab; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Treatment Outcome | 2007 |
[Trials of modulating the MDR1 phenotype in malignant hemopathies].
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Dexamethasone; Doxorubicin; Drug Resistance, Multiple; Humans; Leukemia, Myeloid, Acute; Multiple Myeloma; Quinine; Verapamil; Vincristine | 1994 |
Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Leukemia, Myeloid, Acute; Quinine | 1996 |
Late onset bone marrow transplant nephropathy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Leukemia, Myeloid, Acute; Male; Proteinuria; Radiation Injuries; Time Factors; Transplantation Conditioning; Whole-Body Irradiation | 1996 |
[The causes of treatment ineffectiveness in acute myelogenous leukemia--the role of blast resistance to cytotoxic drugs].
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow Cells; Cyclosporine; Cyclosporins; Cytarabine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Leukemia, Myeloid, Acute; Middle Aged; Survival Rate | 1998 |
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Cystitis; Cytarabine; Cytomegalovirus Infections; DNA, Neoplasm; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Histocompatibility; Humans; Hydroxyurea; Immunosuppressive Agents; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Mitoxantrone; Neoplasms, Second Primary; Prednisolone; Prostaglandins; Remission Induction; Topotecan; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2001 |
27 trial(s) available for cyclosporine and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Assessment of chimerism and immunomodulation to prevent post-transplantation relapse in childhood acute myeloblastic leukemia: is it the right approach?
Topics: Allografts; Child; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunomodulation; Leukemia, Myeloid, Acute; Lymphocyte Transfusion; Male; Prospective Studies; Recurrence; Tissue Donors; Transplantation Chimera | 2020 |
Combination of Low-Dose, Short-Course Mycophenolate Mofetil With Cyclosporine and Methotrexate for Graft-Versus-Host Disease Prophylaxis in Allogeneic Stem Cell Transplant.
Topics: Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Methotrexate; Mycophenolic Acid; Prospective Studies; Stem Cell Transplantation; Treatment Outcome | 2021 |
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cause of Death; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Melphalan; Middle Aged; Myelodysplastic Syndromes; Recurrence; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation; Young Adult | 2017 |
Cyclosporine modulation of multidrug resistance in combination with pravastatin, mitoxantrone and etoposide for adult patients with relapsed/refractory acute myeloid leukemia: a phase 1/2 study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Pravastatin; Treatment Outcome | 2013 |
Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Child; Child, Preschool; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 7; Cyclosporine; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Infant; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Prospective Studies | 2015 |
Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation.
Topics: Adult; Antiretroviral Therapy, Highly Active; CD8-Positive T-Lymphocytes; Cyclosporine; Epitopes; Hematopoietic Stem Cell Transplantation; HIV Infections; HIV-1; Humans; Immune System; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Mycophenolic Acid; Transplantation, Homologous | 2008 |
Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Survival; Cyclosporine; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Fluorescent Dyes; Humans; Idarubicin; Inhibitory Concentration 50; K562 Cells; Leukemia, Myeloid, Acute; Male; Rhodamine 123; Time Factors; Treatment Outcome; Verapamil | 2009 |
Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cytarabine; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epidemiologic Methods; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Proteins; Treatment Outcome | 2010 |
Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome.
Topics: Adenine Nucleotides; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Clofarabine; Cyclosporine; Cytarabine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycophenolic Acid; Myelodysplastic Syndromes; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 2012 |
Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes.
Topics: Adult; Aged; Alanine Transaminase; Aminoglycosides; Anemia, Refractory, with Excess of Blasts; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Cyclosporine; Cytarabine; Female; Gemtuzumab; Humans; Hyperbilirubinemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Survival; Treatment Outcome; Vidarabine | 2003 |
Pilot study of gemtuzumab ozogamicin, liposomal daunorubicin, cytarabine and cyclosporine regimen in patients with refractory acute myelogenous leukemia.
Topics: Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Daunorubicin; Female; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Liposomes; Male; Middle Aged; Pilot Projects; Remission Induction; Salvage Therapy; Treatment Outcome | 2003 |
Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Doxorubicin; Female; Humans; Immunosuppressive Agents; Infant; Karyotyping; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Mitolactol; Remission Induction; Survival Analysis; Tamoxifen; Treatment Outcome | 2006 |
[Peripheral blood stem cell transplantation for 53 patients with malignant hematologic diseases].
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2007 |
Non-myeloablative hematopoietic stem cell transplantation is of limited value in advanced or refractory acute myeloblastic leukemia. The Mexican experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mexico; Middle Aged; Recurrence; Salvage Therapy; Transplantation Conditioning; Treatment Outcome; Vidarabine | 2007 |
A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Survival Rate; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Failure; Vidarabine | 2008 |
Combined transplantation of allogeneic bone marrow and CD34+ blood cells.
Topics: Adult; Antigens, CD; Antigens, CD34; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Whole-Body Irradiation | 1995 |
[Trials of modulating the MDR1 phenotype in malignant hemopathies].
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Dexamethasone; Doxorubicin; Drug Resistance, Multiple; Humans; Leukemia, Myeloid, Acute; Multiple Myeloma; Quinine; Verapamil; Vincristine | 1994 |
Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Hemoglobinuria, Paroxysmal; Humans; Leukemia, Myeloid, Acute; Life Tables; Male; Middle Aged; Prognosis; Salvage Therapy; Survival Rate; T-Lymphocytes; Treatment Outcome | 1995 |
Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO).
Topics: Adolescent; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Humans; Infant; Leukemia, Myeloid, Acute; Leukocytes; Male; Methotrexate; Multivariate Analysis; Recurrence; Remission Induction; Risk Factors; Transplantation, Homologous; Whole-Body Irradiation | 1994 |
Outcome of BMT during first complete remission of AML: a comparison of two sequential studies by the Children's Cancer Group.
Topics: Adult; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid, Acute; Male; Methotrexate; Prognosis | 1993 |
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Chemotherapy, Adjuvant; Creatinine; Cyclosporine; Cytarabine; Feasibility Studies; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Treatment Outcome | 1998 |
Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lymphocyte Depletion; Methotrexate; Multivariate Analysis; Prognosis; Time Factors; Transplantation Conditioning; Treatment Outcome | 1998 |
Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclosporine; Drug Resistance, Multiple; Etoposide; Female; Flow Cytometry; Genes, MDR; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome | 2000 |
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.
Topics: Adult; Aged; Aging; Cause of Death; Cyclosporine; Female; Graft Rejection; Graft vs Tumor Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Neutrophils; Platelet Count; Remission Induction; Survival Rate; T-Lymphocytes; Transplantation Conditioning; Whole-Body Irradiation | 2001 |
Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cytarabine; Cytogenetic Analysis; Daunorubicin; Disease-Free Survival; Drug Interactions; Drug Resistance, Neoplasm; Gene Expression; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Risk Factors | 2001 |
Autologous and allogeneic bone marrow transplantation for childhood acute nonlymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Cyclophosphamide; Cyclosporine; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Melphalan; Methotrexate; Transplantation, Autologous; Transplantation, Homologous | 1992 |
Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
Topics: Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methotrexate; Time Factors | 1992 |
107 other study(ies) available for cyclosporine and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation.
Topics: Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Methotrexate; Prospective Studies; Recurrence; Siblings; Transplantation Conditioning; United States | 2022 |
Impact of the Addition of Antithymocyte Globulin to Post-Transplantation Cyclophosphamide in Haploidentical Transplantation with Peripheral Blood Compared to Post-Transplantation Cyclophosphamide Alone in Acute Myelogenous Leukemia: A Retrospective Study
Topics: Antilymphocyte Serum; Bone Marrow; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mycophenolic Acid; Retrospective Studies; Transplantation, Haploidentical | 2022 |
Clinical and biological impact of ATP-binding cassette transporter activity in adult acute myeloid leukemia.
Topics: Adult; Antigens, CD34; Cyclosporine; HLA-DR Antigens; Humans; Immunophenotyping; Leukemia, Myeloid, Acute; Prognosis | 2023 |
Cyclophosphamide with cyclosporine A for graft-versus-host disease prophylaxis in adult patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation from human leucocyte antigen-matched donors.
Topics: Adult; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Antigens Class II; HLA Antigens; Humans; Leukemia, Myeloid, Acute; Transplantation Conditioning | 2023 |
Cyclosporine enhances the sensitivity to lenalidomide in MDS/AML in vitro.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cyclosporine; DNA-Binding Proteins; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; Humans; Ikaros Transcription Factor; Lenalidomide; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Muscle Proteins; Myelodysplastic Syndromes; Neoplasm Proteins; Up-Regulation; Xenograft Model Antitumor Assays | 2020 |
Haploidentical Stem Cell Transplantation With Post-transplant Cyclophosphamide for Pediatric Acute Leukemia is Safe and Effective.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Retrospective Studies; Tacrolimus; Tissue Donors; Transplantation Conditioning; Transplantation, Haploidentical | 2021 |
Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Transplantation Conditioning; Unrelated Donors | 2022 |
Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.
Topics: Aged; Aged, 80 and over; Anemia; Antilymphocyte Serum; Antineoplastic Agents; Arsenic; Azacitidine; Chromosome Deletion; Chromosomes, Human, Pair 5; Cyclosporine; Cytarabine; Decitabine; Disease Progression; Enzyme Inhibitors; Erythrocyte Transfusion; Female; Hematinics; Humans; Hydroxyurea; Immunologic Factors; Lenalidomide; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Recurrence; Retreatment; Retrospective Studies; Risk Factors; Survival Rate; Thalidomide; Treatment Failure; Tretinoin; Valproic Acid | 2017 |
[Acquired amegacaryocytic thrombocytopenic purpura hiding acute myeloid leukemia].
Topics: Cyclosporine; Disease Progression; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Megakaryocytes; Myelography; Purpura, Thrombocytopenic; Young Adult | 2017 |
A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Graft Survival; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Middle Aged; Multivariate Analysis; Myeloablative Agonists; Predictive Value of Tests; Survival Analysis; Transplantation, Haploidentical; Young Adult | 2018 |
Delayed-onset inflammatory polyneuropathy without graft versus host disease after bone marrow transplantation.
Topics: Anti-Inflammatory Agents; Bone Marrow Transplantation; Cyclosporine; Demyelinating Diseases; Female; Graft vs Host Disease; Humans; Immunization, Passive; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Multiple Myeloma; Polyneuropathies; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Young Adult | 2018 |
Dielectrophoretic trapping of single leukemic cells using the conventional and compact optical measurement systems.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Separation; Cell Shape; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Electrophoresis; Equipment Design; Fluorescence; Fluorescent Dyes; Humans; Lab-On-A-Chip Devices; Leukemia, Myeloid, Acute; Microscopy, Fluorescence; Rhodamine 123; Single-Cell Analysis | 2019 |
Efficacy and influencing factors of allogeneic hematopoietic stem cell transplantation in treatment of 71 children with leukemia.
Topics: Adolescent; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia; Leukemia, Myeloid, Acute; Male; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Treatment Outcome | 2019 |
Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patients.
Topics: Adult; Anemia, Aplastic; ATP Binding Cassette Transporter, Subfamily B; Cohort Studies; Cyclosporine; Cytochrome P-450 CYP3A; Female; Graft Rejection; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Models, Biological; Myelodysplastic Syndromes; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous | 2014 |
Superior outcome using cyclosporin A alone versus cyclosporin A plus methotrexate for post-transplant immunosuppression in children with acute leukemia undergoing sibling hematopoietic stem cell transplantation.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Germany; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Prevention; Retrospective Studies; Severity of Illness Index; Siblings; Treatment Outcome; Young Adult | 2015 |
Mycophenolate-based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative-related donor stem cell transplantation.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous | 2015 |
NFATc1 as a therapeutic target in FLT3-ITD-positive AML.
Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Proliferation; Cyclosporine; Drug Resistance, Neoplasm; Flow Cytometry; fms-Like Tyrosine Kinase 3; Gene Expression Profiling; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; NFATC Transcription Factors; Niacinamide; Oligonucleotide Array Sequence Analysis; Phenylurea Compounds; Prognosis; Protein Kinase Inhibitors; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Sorafenib; Survival Rate; Tandem Repeat Sequences; Tumor Cells, Cultured | 2015 |
[Efficacy analysis of unrelated cord blood transplantation for 58 acute myelogenous leukemia patients].
Topics: Acute Disease; Adolescent; Cyclosporine; Disease-Free Survival; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Leukemia, Myeloid, Acute; Mycophenolic Acid; Quality of Life; Recurrence; Remission Induction; Retrospective Studies | 2015 |
Tacrolimus-Induced Diabetic Ketoacidosis After Allogeneic Bone Marrow Transplant.
Topics: Bone Marrow Transplantation; Calcineurin Inhibitors; Cyclosporine; Diabetic Ketoacidosis; Drug Monitoring; Drug Substitution; Female; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Tacrolimus; Transplantation, Homologous; Treatment Outcome; Young Adult | 2017 |
Improved outcome of children transplanted for high-risk leukemia by using a new strategy of cyclosporine-based GVHD prophylaxis.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infant; Leukemia, Myeloid, Acute; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Premedication; Risk; Survival Rate; Tissue Donors; Young Adult | 2016 |
Reversible diffusion restriction of optic radiations: A distinct form of cyclosporine induced leukoencephalopathy presenting with visual loss.
Topics: Adult; Blindness; Brain; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Leukoencephalopathies; Neurotoxicity Syndromes | 2016 |
Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil.
Topics: Adolescent; Adult; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Incidence; Japan; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Registries; Survival Rate; Tacrolimus | 2017 |
Graft-Versus-Host Disease in Adolescents and Young Adults (15-24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission.
Topics: Acute Disease; Adolescent; Adult; Child; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Intestinal Diseases; Leukemia, Myeloid, Acute; Methotrexate; Mortality; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Quality of Life; Remission Induction; Severity of Illness Index; Skin Diseases; Survival Rate; Transplantation, Homologous; Young Adult | 2017 |
Successful outcome of allo-SCT in high-risk pediatric AML using chemotherapy-only conditioning and post transplant immunotherapy.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunotherapy; Infant; Leukemia, Myeloid, Acute; Male; Melphalan; Stem Cell Transplantation; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous | 2008 |
[Rhabdomyolysis and renal failure secondary to interaction between simvastatin, ciclosporin A and risperidone in an allogeneic stem cell transplantation patient].
Topics: Acute Kidney Injury; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Postoperative Complications; Rhabdomyolysis; Risperidone; Simvastatin; Stem Cell Transplantation; Transplantation, Homologous | 2008 |
[Sclerodermiform chronic graft-versus-host disease after allogenic peripheral blood stem-cell transplantation].
Topics: Anti-Infective Agents; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Laser-Doppler Flowmetry; Leg Ulcer; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycophenolic Acid; Patient Compliance; Pentoxifylline; Peripheral Blood Stem Cell Transplantation; Physical Therapy Modalities; PUVA Therapy; Scleroderma, Localized; Transplantation, Homologous; Vasodilator Agents | 2009 |
Influence of lactate dehydrogenase and cyclosporine A level on the incidence of acute graft-versus-host disease after allogeneic stem cell transplantation.
Topics: Acute Disease; Adult; Cyclosporine; Female; Graft vs Host Disease; Humans; L-Lactate Dehydrogenase; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Transplantation, Homologous | 2009 |
Reduced intensity conditioning prior to allogeneic stem cell transplantation in first complete remission is effective in patients with acute myeloid leukemia and an intermediate-risk karyotype.
Topics: Adult; Aged; Chromosome Aberrations; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycophenolic Acid; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2010 |
Post-hematopoietic stem cell transplantion immune-mediated cytopenias.
Topics: Adult; Aged; Bone Marrow; Chimerism; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunoglobulins, Intravenous; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Postoperative Complications; Red-Cell Aplasia, Pure; Remission Induction; Thrombocytopenia; Transplantation Conditioning | 2009 |
Is there a role for autologous stem cell transplantation for patients with acute myelogenous leukemia? A retrospective analysis.
Topics: Adult; Antibodies, Monoclonal; Antigens, CD; Antigens, Neoplasm; CD52 Antigen; Chromosome Aberrations; Cyclosporine; Disease-Free Survival; Female; Glycoproteins; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Karyotyping; Leukemia, Myeloid, Acute; Male; Recurrence; Retrospective Studies; Risk Factors; Siblings; South Africa; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome | 2011 |
Acute respiratory distress syndrome as an initial presentation of hemophagocytic lymphohistiocytosis after induction therapy for acute myeloid leukemia.
Topics: Antineoplastic Agents; Bone Marrow; Cyclosporine; Fatal Outcome; Female; Ferritins; Humans; Infant, Newborn; Leukemia, Myeloid, Acute; Lymphohistiocytosis, Hemophagocytic; Prognosis; Receptors, Interleukin-2; Respiratory Distress Syndrome | 2011 |
Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation.
Topics: Adult; Aged; Antineoplastic Agents; Cord Blood Stem Cell Transplantation; Cyclosporine; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Mycophenolic Acid; Myeloablative Agonists; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation; Young Adult | 2011 |
The use of selective immunosuppressive therapy on myelodysplastic syndromes in targeted populations results in good response rates and avoids treatment-related disease progression.
Topics: Adolescent; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Bone Marrow Cells; Cell Transformation, Neoplastic; Child; Cyclosporine; Disease Progression; Female; Humans; Immunosuppressive Agents; Karyotype; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; T-Lymphocytes; Treatment Outcome; Young Adult | 2012 |
Marrow versus blood-derived stem cell grafts for allogeneic transplantation from unrelated donors in patients with active myeloid leukemia or myelodysplasia.
Topics: Adolescent; Adult; Antilymphocyte Serum; Antineoplastic Agents; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Germany; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Secondary Prevention; Severity of Illness Index; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors | 2012 |
Extensive gingival and respiratory tract Kaposi sarcoma in a child after allogenic hematopoietic stem cell transplantation.
Topics: Child; Cyclosporine; Gingival Neoplasms; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Prednisolone; Sarcoma, Kaposi; Transplantation, Homologous | 2012 |
11q23 rearrangement and duplication of MLLT1-MLL gene fusion in therapy-related acute myeloid leukemia.
Topics: Azathioprine; Chromosome Banding; Chromosomes, Human, Pair 11; Cyclosporine; Female; Gene Duplication; Hepatitis, Autoimmune; Histone-Lysine N-Methyltransferase; Humans; Immunosuppressive Agents; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Nuclear Proteins; Oncogene Proteins, Fusion; Transcription Factors; Translocation, Genetic; Young Adult | 2012 |
Radiation-free allogeneic conditioning with fludarabine, carmustine, and thiotepa for acute lymphoblastic leukemia and other hematologic malignancies necessitating enhanced central nervous system activity.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal, Humanized; Carmustine; Central Nervous System; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Survival Analysis; Thiotepa; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2012 |
Flow cytometry-based assessment of mitoxantrone efflux from leukemic blasts varies with response to induction chemotherapy in acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cyclosporine; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Female; Flow Cytometry; Humans; Induction Chemotherapy; Karyotype; Leukemia, Myeloid, Acute; Lymphoid Progenitor Cells; Male; Middle Aged; Mitoxantrone; Neoplasm Proteins; Statistics, Nonparametric; Young Adult | 2012 |
Recurrent acute myositis after allogeneic bone marrow transplantation for myelodysplasia.
Topics: Bone Marrow Transplantation; Cyclosporine; Female; Humans; Immune System; Leukemia, Myeloid, Acute; Middle Aged; Myositis; Neural Tube Defects; Recurrence; Transplantation, Homologous | 2002 |
Acute myelogenous leukemia following treatment with cyclosporin A in a nephrotic patient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclosporine; Cytarabine; Daunorubicin; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Nephrotic Syndrome; Treatment Outcome | 2002 |
Prognostic value of cyclic GMP in patients undergoing allogeneic bone marrow transplantation after conditioning with total body irradiation.
Topics: Adolescent; Adult; Biomarkers; Blast Crisis; Bone Marrow Transplantation; Cyclic GMP; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Monitoring, Physiologic; Myelodysplastic Syndromes; Neoplasm Staging; Nitric Oxide; Prognosis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2003 |
Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Topics: Aged; Cyclosporine; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Psoriasis; Remission Induction; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2003 |
[Human leukocyte antigen mismatched hemopietic stem cell transplants for the treatment of leukemia].
Topics: Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Histocompatibility Antigens Class II; HLA Antigens; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methotrexate; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous | 2003 |
Pharmacokinetic interaction between voriconazole and ciclosporin A following allogeneic bone marrow transplantation.
Topics: Adolescent; Antifungal Agents; Bone Marrow Transplantation; Cyclosporine; Drug Interactions; Female; Humans; Leukemia, Myeloid, Acute; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
[Hypercholesterolemia as a part of chronic GVHD after allogeneic stem cell transplantation].
Topics: Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Hypercholesterolemia; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Middle Aged; Prednisolone; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Ursodeoxycholic Acid | 2004 |
[Mismatched hematopoietic stem cell transplantation using GIAC protocol: report of 100 cases].
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous | 2004 |
Graft-versus-host disease of the kidney after rapid tapering of cyclosporin following reduced intensity hematopoietic stem cell transplantation.
Topics: Acute Kidney Injury; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Renal Dialysis | 2005 |
PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Binding Sites; Biological Transport, Active; Cyclosporine; Female; GABA-A Receptor Agonists; HL-60 Cells; Humans; Isoquinolines; Leukemia, Myeloid, Acute; Ligands; Male; Mitochondria; Neoplasm Proteins; Protein Binding; Receptors, GABA-A | 2005 |
Acute myeloid leukemia after intensive immunosuppressive therapy in aplastic anemia.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Child; Cyclosporine; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male | 2005 |
Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.
Topics: Adolescent; Adult; Aged; Cyclosporine; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Leukemia, Myeloid, Acute; Living Donors; Male; Middle Aged; Mycophenolic Acid; Radiotherapy Dosage; Survival Analysis; Time Factors; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation | 2006 |
Allogeneic peripheral blood hematopoietic stem cell transplantation for patients with hematologic malignancies.
Topics: Adolescent; Adult; Child; China; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Sepsis | 2006 |
Does modulation of P-glycoprotein have clinical relevance in pediatric acute myeloid leukemia?
Topics: Adult; Age Factors; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Child, Preschool; Cyclosporine; Drug Resistance, Neoplasm; Female; Flow Cytometry; Gene Expression Regulation, Leukemic; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Randomized Controlled Trials as Topic; Remission Induction | 2006 |
[Clinical study on haploid HLA-matched hematopoietic stem cell transplantation for treatment of malignant hematological disease].
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Basiliximab; Bone Marrow Transplantation; Child; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Haploidy; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Fusion Proteins; Survival Rate; Transplantation Conditioning; Young Adult | 2006 |
Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulin.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Antineoplastic Agents; Busulfan; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2007 |
Upregulation of multi drug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cytarabine; Doxorubicin; Drug Resistance, Multiple; Drug Therapy, Combination; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Lewis X Antigen; Multidrug Resistance-Associated Proteins; Receptors, IgG; Up-Regulation | 2007 |
Calcineurin inhibitor-mediated bilateral hippocampal injury after bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Brain Damage, Chronic; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Enzyme Inhibitors; Female; Hippocampus; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Memory Disorders; Neuropsychological Tests; Neurotoxicity Syndromes; Tacrolimus | 2008 |
[Pyoderma gangrenosum as a precursor of myeloid leukemia].
Topics: Adult; Combined Modality Therapy; Cyclosporine; Dapsone; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Methylprednisolone; Paraneoplastic Syndromes; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Second; Pyoderma Gangrenosum; Recurrence; Skin Transplantation | 1995 |
Hematopoietic growth factors in rheumatoid arthritis: a critical approach to their use in view of possible adverse effects.
Topics: Adult; Arthritis, Rheumatoid; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leucovorin; Leukemia, Myeloid, Acute; Methotrexate; Neutropenia; Prednisolone | 1993 |
Acute myelogenous leukemia in a rheumatoid arthritis patient under cyclosporine A therapy.
Topics: Arthritis, Rheumatoid; Cyclosporine; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged | 1994 |
Intraoral pyogenic granuloma after allogeneic bone marrow transplant. Report of three cases.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Gingival Hyperplasia; Graft vs Host Disease; Granuloma, Pyogenic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Male; Middle Aged; Mouth Diseases | 1994 |
Cyclosporine-induced autologous graft versus host disease: assessment of cytolytic effector mechanisms and the V beta T-cell receptor repertoire.
Topics: Antigens, CD; Bone Marrow Transplantation; Breast Neoplasms; Cyclosporine; Cytotoxicity, Immunologic; Gene Expression; Graft vs Host Disease; Histocompatibility Antigens Class I; HLA-D Antigens; Humans; Immunophenotyping; Killer Cells, Natural; Leukemia, Myeloid, Acute; Lymphocyte Activation; Lymphoma, Non-Hodgkin; Polymerase Chain Reaction; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Antigen, T-Cell, gamma-delta; Skin; T-Lymphocytes; Transplantation, Autologous | 1995 |
Graft failure in children receiving HLA-mismatched marrow transplants with busulfan-containing regimens.
Topics: Adolescent; Adult; Age Factors; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Cytarabine; Drug Therapy, Combination; Graft Rejection; Histocompatibility; HLA Antigens; Humans; Incidence; Leukemia, Myeloid, Acute; Middle Aged; Myelodysplastic Syndromes; Risk Factors; Tissue Donors | 1994 |
Bone marrow transplantation for primary refractory acute leukaemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Remission Induction; Survival Rate | 1994 |
Fulminant hepatitis following bone marrow transplantation in hepatitis B virus carrier siblings.
Topics: Adult; Bone Marrow Transplantation; Carrier State; Cyclosporine; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Leukemia, Myeloid, Acute; Male | 1994 |
Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
Topics: Adolescent; Adult; Age Factors; Aged; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Retrospective Studies; Risk Factors; Survival Rate | 1994 |
Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemia.
Topics: Adult; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Carrier Proteins; Cell Survival; Cyclosporine; Daunorubicin; Drug Resistance; Female; Humans; Leukemia, Myeloid, Acute; Male; Membrane Glycoproteins; Middle Aged; Tumor Cells, Cultured; Verapamil | 1993 |
Synergistic reversal of multidrug-resistance phenotype in acute myeloid leukemia cells by cyclosporin A and cremophor EL.
Topics: Cell Survival; Cyclosporine; Daunorubicin; Drug Resistance; Drug Synergism; Female; Glycerol; Humans; Leukemia, Myeloid, Acute; Male; Tumor Cells, Cultured | 1994 |
Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation for acute myeloid leukemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Middle Aged; Survival Rate | 1993 |
Cyclosporine as possible prophylaxis for obstructive airways disease after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lung Diseases, Obstructive; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Prospective Studies; Respiratory Function Tests; Retrospective Studies; Risk Factors; Transplantation, Homologous | 1993 |
High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation.
Topics: Adult; Base Sequence; Bone Marrow; Bone Marrow Transplantation; Cyclosporine; DNA, Viral; Graft vs Host Disease; Humans; JC Virus; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphocytes; Male; Molecular Sequence Data; Oligodeoxyribonucleotides; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RNA Probes; Transplantation, Homologous; Tumor Virus Infections | 1993 |
Acute graft-versus-host disease prophylaxis with methotrexate and cyclosporine after busulfan and cyclophosphamide in patients with hematologic malignancies.
Topics: Adult; Busulfan; Chronic Disease; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors | 1993 |
Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Humans; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1993 |
New statistical strategy for monitoring safety and efficacy in single-arm clinical trials.
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Clinical Trials, Phase II as Topic; Cyclosporine; Cytarabine; Humans; Idarubicin; Leukemia, Myeloid, Acute; Mathematical Computing; Monitoring, Physiologic; Probability; Remission Induction; Research Design | 1996 |
Transformation of severe aplastic anemia into acute myeloblastic leukemia with monosomy 7.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Transplantation; Chromosomes, Human, Pair 7; Cyclosporine; Erythropoietin; Granulocyte Colony-Stimulating Factor; Humans; Interleukin-6; Leukemia, Myeloid, Acute; Male; Monosomy | 1996 |
Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by Bayesian and non-linear least squares methods.
Topics: Adult; Aged; Bayes Theorem; Cyclosporine; Drug Resistance, Multiple; Female; Hematologic Diseases; Humans; Least-Squares Analysis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1995 |
Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Survival Rate; Time Factors; Transplantation, Homologous; Whole-Body Irradiation | 1996 |
Isolation and characterization of daunorubicin-resistant AML-2 sublines.
Topics: Adenosine Triphosphate; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Cell Separation; Cyanides; Cyclosporine; Daunorubicin; DNA Primers; Drug Resistance, Multiple; Humans; Leukemia, Myeloid, Acute; Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 1997 |
Therapeutic effect of cyclosporine A in thrombocytopenia after myeloablative chemotherapy in acute myeloid leukaemia.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Platelet Count; Thrombocytopenia; Transplantation Conditioning | 1997 |
Clinical approach to circumvention of multidrug resistance in refractory leukemic patients: association of cyclosporin A with etoposide.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Child; Cyclosporine; Drug Resistance, Multiple; Etoposide; Female; Growth Inhibitors; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1997 |
[Detection of multidrug resistance in patients with leukemia by using flow cytometry and RNA in situ hybridization].
Topics: Adult; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flow Cytometry; Gene Expression; Genes, MDR; Humans; Immunosuppressive Agents; In Situ Hybridization; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1996 |
[Hypoplastic myelodysplastic syndrome progressing to acute myelocytic leukemia (M2) after treatment with G-CSF and immunosuppressants].
Topics: Adult; Anemia, Aplastic; Cyclosporine; Diagnosis, Differential; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Pancytopenia; Pregnancy; Pregnancy Complications, Hematologic; Purpura, Thrombocytopenic, Idiopathic | 1998 |
Allogeneic and autologous bone marrow transplantation in single centre experience.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Hodgkin Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Registries; Transplantation, Autologous; Transplantation, Homologous | 1998 |
[Eczema-like cutaneous graft versus host disease treated by UV-B therapy in a 2-year-old child].
Topics: Adrenal Cortex Hormones; Bone Marrow Transplantation; Child, Preschool; Combined Modality Therapy; Cyclosporine; Eczema; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid, Acute; Living Donors; Male; Scalp; Ultraviolet Therapy | 1999 |
Posterior leukoencephalopathy syndrome may not be reversible.
Topics: Bone Marrow Transplantation; Brain Diseases; Child, Preschool; Chromosomes, Human, Pair 7; Cyclosporine; Disease Progression; Humans; Hypertension, Malignant; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Male; Monosomy; Myelodysplastic Syndromes; Occipital Lobe; Ocular Motility Disorders; Syndrome; Tomography, X-Ray Computed | 1999 |
Rapid tapering of cyclosporin to maximise the graft-versus-leukaemia effect.
Topics: Bone Marrow Transplantation; Cyclosporine; Drug Administration Schedule; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute | 1999 |
A new preconditioning regimen with melphalan, busulphan and total body irradiation followed by low-dose immunosuppressant in allogeneic haemopoietic stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cyclosporine; Disease-Free Survival; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Melphalan; Middle Aged; Tacrolimus; Whole-Body Irradiation | 1999 |
Drug concentration-dependent expression of multidrug resistance-associated protein and P-glycoprotein in the doxorubicin-resistant acute myelogenous leukemia sublines.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Gene Expression; Humans; Leukemia, Myeloid, Acute; Multidrug Resistance-Associated Proteins; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Verapamil | 1999 |
Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia.
Topics: Cyclosporine; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Idarubicin; Leukemia, Myeloid, Acute; Time Factors; Verapamil | 1999 |
Comparison of P-glycoprotein expression and function with in vitro sensitivity to anthracyclines in AML.
Topics: Acridines; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Bone Marrow; Cell Survival; Cyclosporine; Daunorubicin; Gene Expression Regulation, Neoplastic; Humans; Isoquinolines; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Recurrence; Tetrahydroisoquinolines; Tumor Cells, Cultured | 1999 |
Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Blast Crisis; Bone Marrow Cells; Cyclosporine; Cyclosporins; Daunorubicin; Drug Resistance, Multiple; Flow Cytometry; Genes, MDR; Humans; Leukemia, Myeloid, Acute; Multidrug Resistance-Associated Proteins; Reproducibility of Results | 1999 |
Both Pgp and MRP1 activities using calcein-AM contribute to drug resistance in AML.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Pair Mismatch; Biological Transport; Calcium; Cyclosporine; DNA-Binding Proteins; Drug Resistance, Multiple; Female; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Genes, MDR; Humans; K562 Cells; Leukemia, Myeloid, Acute; Male; Multidrug Resistance-Associated Proteins; MutS Homolog 3 Protein; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1999 |
MTT assay for drug resistance in childhood acute leukemia and effect of cyclosporin and interferon. A preliminary report.
Topics: Antineoplastic Agents; Bone Marrow; Cell Survival; Child; Cyclosporine; Drug Screening Assays, Antitumor; Humans; Idarubicin; Interferon alpha-2; Interferon-alpha; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Recombinant Proteins; Tumor Cells, Cultured | 1999 |
Cyclosporine-induced autologous graft-versus-host disease in patients with acute myeloid leukemia undergoing non-myeloablative chemotherapy without progenitor cell reinfusion.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cyclophosphamide; Cyclosporine; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Interferon-gamma; Killer Cells, Natural; Leukemia, Myeloid, Acute; Male; Middle Aged; Skin; T-Lymphocyte Subsets | 1999 |
Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy.
Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Transplantation Conditioning | 2000 |
Cyclosporine-induced encephalopathy in a patient with relapsed acute myeloid leukemia treated with unrelated allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Brain Diseases; Cyclosporine; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Transplantation, Homologous | 2000 |
Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Topics: Antineoplastic Agents, Phytogenic; Child, Preschool; Cyclosporine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Neoplasms, Second Primary | 2001 |
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia.
Topics: Adult; Antigens, CD34; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-CD8 Ratio; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hepatitis C; HIV; HIV Infections; Humans; Leukemia, Myeloid, Acute; Remission Induction; RNA, Viral; Transplantation, Homologous; Viremia | 2002 |
Chlamydia pneumoniae respiratory infection after allogeneic stem cell transplantation.
Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydophila pneumoniae; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Penicillium; Respiratory Tract Infections; Transplantation, Homologous; Whole-Body Irradiation | 2002 |
Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry.
Topics: Adult; Age Factors; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Middle Aged; Multivariate Analysis; Registries; Retrospective Studies; Risk Factors; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2002 |
Pure red cell aplasia developing into myeloproliferation with myelodysplasia and subsequent leukemia after cyclosporin A therapy.
Topics: Cell Division; Chromosomes, Human, Pair 8; Cyclosporine; Fatal Outcome; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Myeloproliferative Disorders; Red-Cell Aplasia, Pure; Trisomy | 2002 |
In vitro effect of P-glycoprotein (P-gp) modulators on drug sensitivity of leukemic progenitors (CFU-L) in acute myelogenous leukemia (AML).
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cefoperazone; Cyclosporine; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Membrane Glycoproteins; Middle Aged; Mitoxantrone; Stem Cells; Tumor Cells, Cultured; Verapamil | 1992 |
P-glycoprotein expression in refractory hematological neoplasms and circumvention of resistance with verapamil or cyclosporine A containing protocols.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Carrier Proteins; Cyclosporine; Drug Resistance; Gene Expression; Humans; Immunophenotyping; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Membrane Glycoproteins; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Verapamil | 1992 |
Case report: fulminant hepatitis C viral infection after allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Hepatitis C; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male | 1992 |
Epidermolysis bullosa acquisita, a rare late complication of allogeneic bone marrow transplantation?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Epidermolysis Bullosa Acquisita; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Prednisone; Remission Induction; Transplantation, Homologous | 1992 |
Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia.
Topics: Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Skin; Skin Diseases | 1992 |
Withdrawal of immunosuppressive therapy in allogeneic bone marrow transplantation reactivates chronic viral hepatitis C.
Topics: Adult; Base Sequence; Bone Marrow Transplantation; Cyclosporine; DNA, Viral; Female; Hepacivirus; Hepatitis C; Hepatitis, Chronic; Humans; Leukemia, Myeloid, Acute; Molecular Sequence Data | 1991 |
[The analysis of leukemic relapse after allogeneic bone marrow transplantation].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Postoperative Complications; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation, Homologous | 1991 |